BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28729136)

  • 1. Heparinase enables reliable quantification of circulating tumor DNA from heparinized plasma samples by droplet digital PCR.
    Sefrioui D; Beaussire L; Clatot F; Delacour J; Perdrix A; Frebourg T; Michel P; Di Fiore F; Sarafan-Vasseur N
    Clin Chim Acta; 2017 Sep; 472():75-79. PubMed ID: 28729136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction.
    Pardoe IU; Michalak TI
    J Virol Methods; 1995 Feb; 51(2-3):277-88. PubMed ID: 7738148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified high-throughput quantification of plasma microRNAs in heparinized patients with coronary artery disease using heparinase.
    Li S; Zhang F; Cui Y; Wu M; Lee C; Song J; Cao C; Chen H
    Biochem Biophys Res Commun; 2017 Nov; 493(1):556-561. PubMed ID: 28867189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
    Valpione S; Campana L
    Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of circulating tumor DNA stability In K
    Kang Q; Henry NL; Paoletti C; Jiang H; Vats P; Chinnaiyan AM; Hayes DF; Merajver SD; Rae JM; Tewari M
    Clin Biochem; 2016 Dec; 49(18):1354-1360. PubMed ID: 27129799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titration of heparinase for removal of the PCR-inhibitory effect of heparin in DNA samples.
    Taylor AC
    Mol Ecol; 1997 Apr; 6(4):383-5. PubMed ID: 9131813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker.
    Pietrasz D; Pécuchet N; Garlan F; Didelot A; Dubreuil O; Doat S; Imbert-Bismut F; Karoui M; Vaillant JC; Taly V; Laurent-Puig P; Bachet JB
    Clin Cancer Res; 2017 Jan; 23(1):116-123. PubMed ID: 27993964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma.
    Strijker M; Soer EC; de Pastena M; Creemers A; Balduzzi A; Beagan JJ; Busch OR; van Delden OM; Halfwerk H; van Hooft JE; van Lienden KP; Marchegiani G; Meijer SL; van Noesel CJ; Reinten RJ; Roos E; Schokker S; Verheij J; van de Vijver MJ; Waasdorp C; Wilmink JW; Ylstra B; Besselink MG; Bijlsma MF; Dijk F; van Laarhoven HW
    Int J Cancer; 2020 Mar; 146(5):1445-1456. PubMed ID: 31340061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients.
    Sánchez-Martín V; López-López E; Reguero-Paredes D; Godoy-Ortiz A; Domínguez-Recio ME; Jiménez-Rodríguez B; Alba-Bernal A; Elena Quirós-Ortega M; Roldán-Díaz MD; Velasco-Suelto J; Linares-Valencia N; Garrido-Aranda A; Lavado-Valenzuela R; Álvarez M; Pascual J; Alba E; Comino-Méndez I
    Clin Chim Acta; 2024 Jan; 552():117673. PubMed ID: 38007055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct circulating tumor DNA detection from unpurified plasma using a digital PCR platform.
    Sefrioui D; Beaussire L; Perdrix A; Clatot F; Michel P; Frebourg T; Di Fiore F; Sarafan-Vasseur N
    Clin Biochem; 2017 Nov; 50(16-17):963-966. PubMed ID: 28645720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaboratory assessment of droplet digital PCR for quantification of BRAF V600E mutation using a novel DNA reference material.
    Dong L; Wang X; Wang S; Du M; Niu C; Yang J; Li L; Zhang G; Fu B; Gao Y; Wang J
    Talanta; 2020 Jan; 207():120293. PubMed ID: 31594564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.
    Gorgannezhad L; Umer M; Islam MN; Nguyen NT; Shiddiky MJA
    Lab Chip; 2018 Apr; 18(8):1174-1196. PubMed ID: 29569666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Treatment of Heparinized Blood Fractions to Make Them Suitable for Analysis.
    Sánchez-Fito MT; Oltra E
    Biopreserv Biobank; 2015 Aug; 13(4):287-95. PubMed ID: 26280503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparinase treatment of heparin-contaminated plasma from coronary artery bypass grafting patients enables reliable quantification of microRNAs.
    Kondratov K; Kurapeev D; Popov M; Sidorova M; Minasian S; Galagudza M; Kostareva A; Fedorov A
    Biomol Detect Quantif; 2016 Jun; 8():9-14. PubMed ID: 27335806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
    Yang X; Zhuo M; Ye X; Bai H; Wang Z; Sun Y; Zhao J; An T; Duan J; Wu M; Wang J
    Oncotarget; 2016 Apr; 7(15):20810-24. PubMed ID: 26989078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer.
    Hrebien S; O'Leary B; Beaney M; Schiavon G; Fribbens C; Bhambra A; Johnson R; Garcia-Murillas I; Turner N
    PLoS One; 2016; 11(10):e0165023. PubMed ID: 27760227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating Tumor DNA (ctDNA) Detection Using BEAMing and Its Clinical Significance.].
    Nakamura K
    Rinsho Byori; 2016 May; 64(4):400-406. PubMed ID: 29182806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma.
    Beinse G; Borghese B; Métairie M; Just PA; Poulet G; Garinet S; Parfait B; Didelot A; Bourreau C; Agueeff N; Lavollé A; Terris B; Chapron C; Goldwasser F; Leroy K; Blons H; Laurent-Puig P; Taly V; Alexandre J
    Clin Chem; 2022 Jun; 68(6):782-793. PubMed ID: 35323926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis.
    Urso L; Vernaci G; Carlet J; Lo Mele M; Fassan M; Zulato E; Faggioni G; Menichetti A; Di Liso E; Griguolo G; Falci C; Conte P; Indraccolo S; Guarneri V; Dieci MV
    Front Oncol; 2021; 11():625636. PubMed ID: 33777770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.